Antibody responses after hepatitis B vaccination among maintenance haemodialysis patients

Bangladesh Medical Research Council Bulletin

Volumn 37, Issue 3, 2011, Pages 88-91

  Nahar, K ^a   Jahan, M ^b   Nessa, A ^b   Tabassum, S ^b  

^a Islamia Eye Hospital   (Bangladesh)

^b BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; INFECTION PREVENTION; MALE;

EID: 83255185479     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v37i3.9119     Document Type: Article

References (36)

1. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25: S3-S9.
2. CDC (2007).Viral Hepatitis B Fact Sheet. (Accessed January 6, 2008, at http:// www.cdc.gov/nip).
3. Huan CC. Hepatitis infection in haemodialysis patients. Nephrology 2002; 7: 101-109.
4. Margeridon S, Lachaux A, Trepo C, Zoulim F, Kay AA. quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus. J Gen Virol 2005; 8: 1687-93. (Pubitemid 40766880)
5. Taheri Sh., Shahidi Sh., Moghtaderi J, Seirafian Sh, Emami A, Eftekhari SM. Response Rate to Hepatitis B Vaccination in Patients with Chronic Renal Failure and End-Stage-Renal-disease: Influence of Diabetes Mellitus. JRMS 2005; 10(6): 384-390. (Pubitemid 41824498)
6. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immuno Med Micro 1999; 26: 259-265.
7. CDC (2006). Guidelines for Vaccinating Kidney Dialysis Patients and Patients with Chronic kidney Disease. (Accessed January 7, 2007, at http://www.cdc.gov).
8. CDC (2001). Hepatitis B vaccine. (Accessed January 6, 2008, at www.cdc.gov/nip).
9. Tong NK, Beran J, Kee SA, Miguel JL, Sánchez C, Bayas JM, Vilella A, de Juanes JR, Arrazola P, Calbo-Torrecillas F, de Novales EL, Hamtiaux V, Lievens M, Stoffel M. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-haemodialysis and haemodialysis patients. Kidney Int 2005;68:2298-2303. (Pubitemid 43117807)
10. DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, Kiaii M, Taylor PA, Levin A. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 2003; 42(6): 1184-92. (Pubitemid 37486762)
11. Liu YL, Kao MT, Huang CC. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 2005; 23: 3957-3960.
12. Bel'eed K, Wright M, Eadington D, Farr M, Sellars L. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad Med J 2002; 78(923): 538-40. (Pubitemid 35176657)
13. PBHLS (Public Health Laboratory Service). Hepatitis B in retreat from dialysis units in United Kingdom in 1973. Br Med J 1976; 26:1579-1581.
14. Kohler H. Hepatitis B immunization in dialysis patients- is it worth-while? Nephrol Dial Transplant 1994; 9: 1719-1720.
15. Miller RW. Radiation, chromosomes and viruses in the aetiology of leukaemia. Evidence from epidemiologic research. New Engl J Med 1964; 271:30.
16. Chin AI. Hepatitis B Virus Vaccine Response in Haemodialysis: Baseline Patient Characteristics. Hemodial Int 2003; 7(4): 296-303.
17. Charest AF, McDougall J, Goldstein MB. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 2000; 36:976-982.
18. Sezer S, Ozdemir F.N, Guz G, Arat Z, Colak T, Sengul S. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplantation proceedings 2000; 32: 607-608. (Pubitemid 30254424)
19. Girndt M, Sester M, Sester U, Kaul H, Kohler, H. Defective expression of B7-2 (CD68) on monocytes of dialysis patients correlates to the uremia associated immune defect. Kid Int 2001; 59:1382-1389. (Pubitemid 32281226)
20. NHS (Primary Care Trust) (2005). Patient Group Direction for Hepatitis B Vaccine. Retrieved October 2008, from http://www.mbpct.nhs.uk.
21. PDTM (parental drug therapy manual). (Accessed June 01, 2007, at http://www.vhpharmsci.com).
22. Data Sheet. New Zealand. Medicines and medical device safety authority. (Accessed December 11, 2007, at http://www.medsafe.govt.nz/Profs/Datasheet/).
23. WHO (2007). Recommended Adult Immunization Schedule: United States. Retrieved January 11, 2009, at http://vaccines@who.int).
24. Hepatitis B Foundation: vaccine Non-responder (2004). (Accessed September 4,2008, at http://www.info@hepb.org).
25. Kevin SE, Helen EJ, Husam O, Steve AS. Efficacy of accelerated hepatitis B vaccination schedule used in haemodialysis patients post-exposure to virus: a single-centre experience. Nephrol Dial Transplant 2002; 17: 1982-1987.
26. Ramezani A, Eslami A, Ahmadi F, Maziar S, Razeghi E, Kalantar E. Is Any Factor Influence On Hepatitis B Vaccination Response In Hemodialysis Patients? The Internet Journal of Nephrology 2006; 3(2).
27. Centers for Disease Control and Prevention. Recommendation for preventing transmission of infections among chronic haemodialysis patients. MMWR 200; 50: 1-43.
28. West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: Implications for policy on booster vaccination. Vaccine 1996; 14: 1019-27. (Pubitemid 26281288)
29. Sezer S, Ozdemir F.N, Guz G, Arat Z, Colak T, Sengul S. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplantation proceedings 2000; 32: 607-608. (Pubitemid 30254424)
30. Shatat HZ, Kotkat AM, Farghaly AG. Immune response to hepatitis B vaccine in haemodialysis patients. J Egypt Public Health Assoc 2000; 75(3-4): 257-75
31. Peces R, Torre M, Alchzar R, Urra JM. Prospective Analysis of the Factors Influencing the Antibody Response to Hepatitis B Vaccine in Hemodialysis Patients. American Journal of Kidney Diseases 1997; 29(2): 239-245. (Pubitemid 27130735)
32. Marangi AL, Giordano R, Montanaro A. Hepatitis B virus infection in chronic uremia: longterm follow-up of a two-step integrated protocol of va~cination. Am J Kidney Dis 1994; 23: 537-42. (Pubitemid 24109115)
33. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulal G. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther 2004; 20: 1053-1062. (Pubitemid 39657938)
34. Akinodan T, Kay MMB. Age influence on the immune system. In: Kunkel HG, Dixon FG, eds. Advances in immunology. New York: Academic Press, Inc., 1980; 287-330.
35. Douvin C, Simon D, Charles A, Deforges L, Bierling P, Lehner V, Budkowska A. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen. Diabetes care 1997; 20(2): 148-151. (Pubitemid 27051551)
36. Steketee, R. W., Ziarnik, M. E., & Davis, J. P. (1988). Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers. Am J Eptoemlol 127: 772-82.